Wegman Mark N 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Jun 20, 2018
Insider Transaction Report
Form 4
Wegman Mark N
Director
Transactions
- Conversion
Common Stock, $0.001 par value
2018-06-20$17.00/sh+15,000$255,000→ 80,272 total - Conversion
Stock Option (Right to Buy)
2018-06-20−15,000→ 0 totalExercise: $17.00Exp: 2018-06-25→ Cmn Stk $.001pv (15,000 underlying)
Footnotes (1)
- [F1]The option vests monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested.